1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Stanger, H.E.
Syud, F.A.
Espinosa, J.F.
Giriat, I.
Muir, T.
Gellman, S.H.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C5 H9 N O2
115.130
D-PROLINE
D-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Proc.Natl.Acad.Sci.USA
PNASA6
0040
0027-8424
98
12015
12020
10.1073/pnas.211536998
11593011
Length-dependent stability and strand length limits in antiparallel beta -sheet secondary structure.
2001
10.2210/pdb1jy9/pdb
pdb_00001jy9
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
1
SINGLE WAVELENGTH
M
1
1.0
2241.559
DP-TT2
1
syn
polymer
no
yes
TTTTRYVEV(DPR)GKKILQTTTT
TTTTRYVEVPGKKILQTTTT
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
database_2
pdbx_struct_assembly
pdbx_struct_oper_list
struct_conn
repository
Initial release
Version format compliance
Version format compliance
Database references
Derived calculations
1
0
2001-09-19
1
1
2008-04-27
1
2
2011-07-13
1
3
2022-02-23
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_struct_conn.pdbx_leaving_atom_flag
SEQUENCE
RESIDUE 12 IN THE PEPTIDE IS ORNITHINE.
FOR MODELLING, LYSINE WAS USED IN PLACE
OF ORNITHINE FOR EASE OF CALCULATION.
RCSB
Y
RCSB
2001-09-11
REL
REL
The peptide was synthesized by solid phase peptide synthesis.
sample
ROESY to check for spin diffusion.
1
2D NOESY
3.8
ambient
277
K
NOE intensities were qualitatively assigned to be strong, medium, weak or very weak, and assigned constraints of 3, 4, 5, and 6 respectively; a total of 32 restraints were used for DP-TT2. Restraints were checked using "distance check" function within DYANA which showed there were no "lonely" or possibly misassigned NOEs which could unduly influence the final conformation. DYANA was used to generate 500 random structures, which were subsequently annealed. The best 10 structures (fewest restraint violations) were selected. This entry contains the minimized average structure.
1 mM peptide
9:1 H2O:D2O, 100 mM Acetic Acid
Guntert, Mumenthaler, Wuthrich
structure solution
DIANA
1.5
Guntert, Mumenthaler, Wuthrich
refinement
DIANA
1.5
600
Varian
INOVA
THR
1
n
1
THR
1
A
THR
2
n
2
THR
2
A
THR
3
n
3
THR
3
A
THR
4
n
4
THR
4
A
ARG
5
n
5
ARG
5
A
TYR
6
n
6
TYR
6
A
VAL
7
n
7
VAL
7
A
GLU
8
n
8
GLU
8
A
VAL
9
n
9
VAL
9
A
PRO
10
n
10
DPR
10
A
GLY
11
n
11
GLY
11
A
LYS
12
n
12
LYS
12
A
LYS
13
n
13
LYS
13
A
ILE
14
n
14
ILE
14
A
LEU
15
n
15
LEU
15
A
GLN
16
n
16
GLN
16
A
THR
17
n
17
THR
17
A
THR
18
n
18
THR
18
A
THR
19
n
19
THR
19
A
THR
20
n
20
THR
20
A
author_defined_assembly
1
monomeric
A
DPR
10
D-PROLINE
A
DPR
10
PRO
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
N
VAL
7
A
N
VAL
7
A
O
ILE
14
A
O
ILE
14
1
A
THR
2
-174.13
-43.06
1
A
LYS
12
-160.13
-91.40
1
A
LYS
13
179.80
-177.41
1
A
ILE
14
-176.36
147.94
1
A
THR
17
-153.93
37.29
MINIMIZED AVERAGE STRUCTURE OF DP-TT2
1
N
N
covale
1.360
both
A
VAL
9
A
C
VAL
9
1_555
A
DPR
10
A
N
DPR
10
1_555
covale
1.324
both
A
DPR
10
A
C
DPR
10
1_555
A
GLY
11
A
N
GLY
11
1_555
DE NOVO PROTEIN
beta-hairpin, DE NOVO PROTEIN
1JY9
PDB
1
1JY9
1
20
1JY9
1
20
1JY9
A
1
1
20
2
anti-parallel
A
TYR
6
A
TYR
6
A
VAL
7
A
VAL
7
A
ILE
14
A
ILE
14
A
LEU
15
A
LEU
15